# Filing Detail

Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-22-085673
Filing Date
2022-08-03
Accepted
2022-08-03 16:47:07
Documents
7
Period of Report
2022-08-03

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PRE 14A | tm2222180d1_pre14a.htm | PRE 14A | 567808
2 | GRAPHIC | image_003.gif | GRAPHIC | 65
3 | GRAPHIC | tm2222180-1_pre14aimag02.jpg | GRAPHIC | 4611
4 | GRAPHIC | tm2222180-1_pre14aimag03.jpg | GRAPHIC | 4613
5 | GRAPHIC | tm2222180d1_pre14aimg004.jpg | GRAPHIC | 236591
6 | GRAPHIC | tm2222180d1_pre14aimg005.jpg | GRAPHIC | 176977
7 | GRAPHIC | tm2222180d1_pre14aimg008.jpg | GRAPHIC | 244706
| Complete submission text file | 0001104659-22-085673.txt |  | 1489648

Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

EIN.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-12584 | Film No.: 221133350
SIC: 2834 Pharmaceutical Preparations